Clinical Trial Update: Mavacamten Pregnancy Surveillance Program

View source ↗

Summary

This ClinicalTrials.gov entry describes a mavacamten pregnancy surveillance program to monitor safety and outcomes in people with hypertrophic cardiomyopathy du…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Breastfeeding, Hypertrophic Cardiomyopathy | Status: RECRUITING